SHINE Medical Technology reaches key milestone
JANESVILLE--A company that plans to build a production plant in Janesville says it has reached a milestone that further demonstrates its ability to produce a medical isotope used in more than 40 million medical imaging tests each year.
SHINE Medical Technologies is working toward regulatory approval of a $85 million production plant that will use low-enriched uranium in a series of eight accelerators to produce molybdenum-99, a medical isotope used in more than 30 kinds of diagnostic imaging procedures performed more than 50,000 times each day in the United States.
SHINE said Wednesday that its development program with Phoenix Nuclear Labs successfully produced neutrons, a major step in validating SHINE’s technology, said Greg Piefer, the company’s founder and chief executive officer.
For a full story, read Friday’s Gazette, read online in the Gazette’s E-Edition or check back at GazetteXtra.com.